Patients’ with Obstructive Sleep Apnoea Syndrome (OSAS) Preferences and Demand for Treatment: A Discrete Choice Experiment

Nicolas Krucien

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

RATIONALE: Despite its high level of effectiveness, initial acceptance of continuous positive airway pressure (CPAP) and regular use in patients with obstructive sleep apnoea syndrome (OSAS) are still an issue. Alternatively, oral appliances (OAs) can be recommended. To improve patient engagement in their treatment, physicians are advised to take into account patient preferences and to share the therapeutic decision. We aimed to determine patients' preferences for OSAS treatment-related attributes, and to predict patients' demand for both CPAP and OAs.
METHODS: A discrete choice experiment (DCE) was performed in 121 newly diagnosed patients consecutively recruited in a sleep unit.
RESULTS: Regression parameters were the highest for impact on daily life and effectiveness ahead of side effects. In the French context, the demanding probabilities for CPAP and OAs were 60.2% and 36.2%, respectively. They were sensitive to the variation in the amount of out-of-pocket expenses for both CPAP and OAs.
CONCLUSIONS: This first DCE in OSAS emphasises the importance to communicate with patients before the implementation of treatment.
Original languageEnglish
Pages (from-to)487-8
Number of pages2
JournalThorax
Volume68
Issue number5
Early online date21 Sep 2012
DOIs
Publication statusPublished - May 2013

Fingerprint

Continuous Positive Airway Pressure
Obstructive Sleep Apnea
Patient Preference
Patient Participation
Therapeutics
Health Expenditures
Sleep
Physicians

Cite this

Patients’ with Obstructive Sleep Apnoea Syndrome (OSAS) Preferences and Demand for Treatment: A Discrete Choice Experiment. / Krucien, Nicolas.

In: Thorax, Vol. 68, No. 5, 05.2013, p. 487-8.

Research output: Contribution to journalArticle

@article{b93df2a7f0424d0c9b7304bde29ca659,
title = "Patients’ with Obstructive Sleep Apnoea Syndrome (OSAS) Preferences and Demand for Treatment: A Discrete Choice Experiment",
abstract = "RATIONALE: Despite its high level of effectiveness, initial acceptance of continuous positive airway pressure (CPAP) and regular use in patients with obstructive sleep apnoea syndrome (OSAS) are still an issue. Alternatively, oral appliances (OAs) can be recommended. To improve patient engagement in their treatment, physicians are advised to take into account patient preferences and to share the therapeutic decision. We aimed to determine patients' preferences for OSAS treatment-related attributes, and to predict patients' demand for both CPAP and OAs.METHODS: A discrete choice experiment (DCE) was performed in 121 newly diagnosed patients consecutively recruited in a sleep unit.RESULTS: Regression parameters were the highest for impact on daily life and effectiveness ahead of side effects. In the French context, the demanding probabilities for CPAP and OAs were 60.2{\%} and 36.2{\%}, respectively. They were sensitive to the variation in the amount of out-of-pocket expenses for both CPAP and OAs.CONCLUSIONS: This first DCE in OSAS emphasises the importance to communicate with patients before the implementation of treatment.",
author = "Nicolas Krucien",
year = "2013",
month = "5",
doi = "10.1136/thoraxjnl-2012-202240",
language = "English",
volume = "68",
pages = "487--8",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group Ltd",
number = "5",

}

TY - JOUR

T1 - Patients’ with Obstructive Sleep Apnoea Syndrome (OSAS) Preferences and Demand for Treatment: A Discrete Choice Experiment

AU - Krucien, Nicolas

PY - 2013/5

Y1 - 2013/5

N2 - RATIONALE: Despite its high level of effectiveness, initial acceptance of continuous positive airway pressure (CPAP) and regular use in patients with obstructive sleep apnoea syndrome (OSAS) are still an issue. Alternatively, oral appliances (OAs) can be recommended. To improve patient engagement in their treatment, physicians are advised to take into account patient preferences and to share the therapeutic decision. We aimed to determine patients' preferences for OSAS treatment-related attributes, and to predict patients' demand for both CPAP and OAs.METHODS: A discrete choice experiment (DCE) was performed in 121 newly diagnosed patients consecutively recruited in a sleep unit.RESULTS: Regression parameters were the highest for impact on daily life and effectiveness ahead of side effects. In the French context, the demanding probabilities for CPAP and OAs were 60.2% and 36.2%, respectively. They were sensitive to the variation in the amount of out-of-pocket expenses for both CPAP and OAs.CONCLUSIONS: This first DCE in OSAS emphasises the importance to communicate with patients before the implementation of treatment.

AB - RATIONALE: Despite its high level of effectiveness, initial acceptance of continuous positive airway pressure (CPAP) and regular use in patients with obstructive sleep apnoea syndrome (OSAS) are still an issue. Alternatively, oral appliances (OAs) can be recommended. To improve patient engagement in their treatment, physicians are advised to take into account patient preferences and to share the therapeutic decision. We aimed to determine patients' preferences for OSAS treatment-related attributes, and to predict patients' demand for both CPAP and OAs.METHODS: A discrete choice experiment (DCE) was performed in 121 newly diagnosed patients consecutively recruited in a sleep unit.RESULTS: Regression parameters were the highest for impact on daily life and effectiveness ahead of side effects. In the French context, the demanding probabilities for CPAP and OAs were 60.2% and 36.2%, respectively. They were sensitive to the variation in the amount of out-of-pocket expenses for both CPAP and OAs.CONCLUSIONS: This first DCE in OSAS emphasises the importance to communicate with patients before the implementation of treatment.

U2 - 10.1136/thoraxjnl-2012-202240

DO - 10.1136/thoraxjnl-2012-202240

M3 - Article

VL - 68

SP - 487

EP - 488

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 5

ER -